Actinium Pharmaceuticals, Inc.
ATNM
$1.45
$0.000.00%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.40% | 56.85% | -139.60% | 42.50% | -1.89% |
| Total Depreciation and Amortization | 0.98% | -0.49% | 0.49% | 0.99% | 6.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.67% | -97.78% | 637.66% | -10.02% | -2.69% |
| Change in Net Operating Assets | -239.08% | 251.75% | -41.30% | 74.00% | -207.04% |
| Cash from Operations | -17.30% | 28.81% | -31.70% | 51.97% | -50.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | -50.00% | 0.00% | 0.00% | 33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -53.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6,866.67% | -50.00% | 33.33% | -100.07% | -53.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.11% | 28.79% | -31.66% | 21.96% | -472.00% |